Subscribe
Launches
4 min read

A Smart Bed Takes On the Pet-Wearable Crowd, No Collar Required

WoafMeow closed a pre-seed round under $1 million, backed by a Hong Kong family office, to build a passive smart bed for aging and sick pets instead of a wearable collar. The platform ambition it's chasing, AI guidance, a vet marketplace, local services, and end-of-life support, is bigger than the check funding it.

Written by
The Underbite
Published on
August 13, 2026
A Smart Bed Takes On the Pet-Wearable Crowd, No Collar Required

Every pet-health-monitoring pitch this year has centered on the collar: Fi's satellite-linked Ultra, Marley Health's biomarker ambitions, Tether's stealth wearable built to catch pain before it visibly shows. A new entrant wants pet owners to skip the collar entirely and let the bed do the sensing instead. WoafMeow closed a pre-seed round, backed by a Hong Kong family office and a group of angels, to build that bed and a much larger aging-care platform on top of it.

A Hong Kong family office backs the sub-$1M round

WoafMeow, based in Los Angeles, builds WoafyPet, an AI-powered orthopedic bed designed for senior dogs, pets with chronic conditions, large breeds, and post-surgical recovery. The bed tracks sleep, weight, activity, nighttime restlessness, resting respiration, and heart-rate trends without a collar, a charger, or any change to a pet's routine, then turns those signals into reports owners can bring to a veterinarian.

The pre-seed round was backed by a Hong Kong family office focused on smart hardware and several angel investors. WoafMeow hasn't disclosed the amount, though The Underbite understands it came in under $1 million. The company said the money will fund mass production, an expanded AI care platform, hiring, supply-chain work, and international expansion ahead of a Kickstarter launch planned for later this year.

Ahead of that launch, WoafMeow says it has built a community of more than 13,000 pet owners and collected paid reservations from nearly 1,000 U.S. buyers, a roughly 7.7% conversion from community member to paying reservation holder. Co-founder Shelly Xie said the company is starting with "the place pets spend the most time resting" before layering on veterinary guidance, local-care referrals, and end-of-life support.

A passive sensor sets WoafMeow apart from wearable rivals

Fi, Marley Health, and Tether are all chasing the same signal, wearable-first. Fi's Ultra collar rides Starlink to justify a $189 annual membership, funded on roughly $45 million raised to date. Marley Health launched a research-backed biomarker collar with Royal Veterinary College and Oxford pedigree, a launch The Underbite covered, without disclosing a funding number. Tether is chasing a related premise from the collar side, catching pain signals before an owner would otherwise notice them. WoafMeow is making the opposite hardware bet, a passive bed that asks nothing of the pet, aimed at senior and post-surgical dogs least tolerant of a collar in the first place.

WoafMeow's ambition goes well past the bed itself. The company's release describes a six-part platform: the sensing hardware, an AI-guidance layer, a veterinary marketplace, a local-services marketplace, an owner community with in-person events, and end-of-life support. That's roughly the same territory Marley is building toward with a research institution behind it, and Fi is building toward with a far larger balance sheet. WoafMeow is starting all six at once from a pre-seed stage.

That's a lot to build in parallel, and it's also the pitch every ambitious early-stage hardware company makes. A no-wearable sensor is a genuine point of differentiation for the aging and post-surgical dogs least likely to tolerate a collar in the first place, and the founding team's self-reported record, five companies built, two prior exits, seven patents, is the kind of resume that can move fast on a narrow scope.

The Kickstarter campaign will test demand beyond the existing list

WoafMeow already has real demand validated before the campaign even opens with 1,000 reservations placed in advance. The number to watch is how that translates once the campaign goes live to the public.

The second is sequencing. Watch whether WoafMeow ships the bed and app first, builds trust with early buyers, and only then layers on the veterinary marketplace, local-services referrals, and community events, or tries to launch pieces of all of it alongside the Kickstarter. Hardware companies that nail the core product before expanding tend to have an easier time building out everything else.

The third is validation. Once real units are in homes, whether WoafyPet's sleep, weight, and respiration signals line up with what a veterinarian finds on exam will matter more to WoafMeow's credibility than anything about the round that funded it.

Source: WoafMeow, submitted directly to The Underbite

This news brief is based on a company-submitted announcement. The Underbite verifies claims where possible but cannot independently confirm all details.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
Vetspire Splits From Thrive, Lands a Battery Ventures Backing
Funding & M&A
4 min read

Vetspire Splits From Thrive, Lands a Battery Ventures Backing

Vetspire has spun out of Thrive Pet Healthcare's orbit with a growth investment from Battery Ventures and a new CEO, Zachary Seely. The AI-powered practice management platform, used by more than 800 veterinary hospitals and clinics, will operate independently while Thrive remains a customer. The deal tests whether AI-native vet software can draw institutional capital without a strategic parent underwriting it.

Read article
Read article
PetMeds Revenue Falls 20% as Takeover Fight Drags On
Earnings
6 min read

PetMeds Revenue Falls 20% as Takeover Fight Drags On

PetMeds' first-quarter revenue fell 19.9% to $41.0 million and cash reserves dropped to $13.1 million, even as the company narrowed its net loss to $6.1 million from $34.2 million a year earlier. The results land as an unsolicited $3-a-share buyout offer from SilverCape Investments remains on the table and a $37 million sale-leaseback of its headquarters awaits closing.

Read article
Read article
FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North
Regulatory
4 min read

FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North

The FDA granted Zoetis an emergency use authorization for Simparica Trio to treat New World screwworm in dogs, the first product cleared specifically for the threat. Texas has already begun requiring treatment before dogs cross certain lines, putting boarding facilities, transporters, and border-state vet practices under a new compliance mandate.

Read article
View all articles